ClinicalTrials.Veeva

Menu

Impact of Hemodialysis on Cutaneo-muscular Electrical Impedance (H-ICMUS)

A

Assistance Publique - Hôpitaux de Paris

Status

Completed

Conditions

Hemodialysis

Study type

Observational

Funder types

Other

Identifiers

NCT04892745
APHP210098
2020-A03337-32 (Registry Identifier)

Details and patient eligibility

About

The primary objective of this pilot study aims to describe the modifications of subcutaneous impedancemetry induced by dialysis.

As secondary objectives, the study aims to 1) describe the modifications of cutaneo-muscular impedancemetry induced by dialysis. 2) describe the relationship between modifications of subcutaneous impedancemetry induced by dialysis and - technical conditions of dialysis; - volemic parameters of dialysis; - evolution of liquid compartments in organism during dialysis; - volemic events or neuromuscular events. 3) describe the relationship between modifications of cutaneo-muscular impedancemetry induced by dialysis and 1) describe the modifications of cutaneo-muscular impedance induced by dialysis. 2) describe the relationship between modifications of subcutaneous impedancemetry induced by dialysis and - technical conditions of dialysis; - volemic parameters of dialysis; - evolution of liquid compartments in organism during dialysis; - volemic events or neuromuscular events.

Full description

The study will be realized in dialysis facility of Ambroise Paré hospital, APHP. The duration of enrollment of subjects will be 3 months, each enrolled patient will has 2 or 3 week's follow-up.

Enrollment

18 patients

Sex

All

Ages

18 to 89 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient ⩾ 18 years;
  • Patient undergoing chronic dialysis in hemodialysis facility of Ambroise Paré hospital;
  • Patient has been informed and given no-opposition for participating to the study.

Exclusion criteria

  • Patient with a pacemaker or an implantable cardioverter defibrillator;
  • Patient under guardianship or curatorship;
  • Foreign patient under french AME scheme.

Trial contacts and locations

1

Loading...

Central trial contact

Marie ESSIG, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems